1. I think you are reading too much into it. I took this to mean Safety study plus separate laboratory testing for potency against other viruses (i.e SARs, MERs, RSV).
2. Very cool stuff. I agree, nice to see a largish concrete number on revenue like this. If UK maintains a steady trickle of sales through 1400 stores and EU does well, might actually end up being cash flow positive at some stage (while still carrying on DEP research). In my opinion, this would be huge. I've done my numbers and have my own opinions on revenue going forward, but it's still early days and easy to see many factors that would interfere with anyone's guesstimates.
1. I think you are reading too much into it. I took this to mean...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.003(3.09%) |
Mkt cap ! $41.73M | |||
| Open | High | Low | Value | Volume |
| 9.9¢ | 10.5¢ | 9.9¢ | $12.72K | 127.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 50204 | 9.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 64981 | 2 |
View Market Depth
| Last trade - 10.43am 18/09/2024 (20 minute delay) ? |
| SPL (ASX) Chart |